ALDER BIOPHARMACEUTICALS INC Business Finance Contracts & Agreements
21 Contracts & Agreements
- Indenture Agreements (3 contracts)
- Investor Rights Agreements (2)
- Registration Rights Agreements (2)
- Stock Agreements (7)
- Underwriting Agreements (7)
- Second Supplemental Indenture, dated October 22, 2019, among Alder BioPharmaceuticals, Inc., Lundbeck LLC, and U.S. Bank National Association (Filed With SEC on October 22, 2019)
- Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement for the 2018 Inducement Award Plan (Filed With SEC on August 6, 2019)
- Registration Rights Agreement by and between Alder BioPharmaceuticals, Inc. and the buyers listed on the Schedule of Buyers thereto, dated March 4, 2019 (Filed With SEC on March 5, 2019)
- Common Stock Purchase Agreement, dated February 26, 2019, by and between Alder BioPharmaceuticals, Inc., Redmile Group, LLC and certain institutional and other accredited... (Filed With SEC on March 1, 2019)
- Underwriting Agreement, dated February 27, 2019 (Filed With SEC on March 1, 2019)
- Form of Stock Option Grant Notice and Option Agreement (Time-Based Vesting) for the 2018 Inducement Award Plan (Filed With SEC on August 7, 2018)
- First Supplemental Indenture, dated February 1, 2018, between the Company and U.S. Bank National Association, as Trustee (including the form of 2.50% convertible senior notes due... (Filed With SEC on February 1, 2018)
- Base Indenture, dated February 1, 2018, between the Company and U.S. Bank National Association, as Trustee (Filed With SEC on February 1, 2018)
- Underwriting Agreement, dated January 29, 2018 (Filed With SEC on February 1, 2018)
- Registration Rights Agreement by and between Alder BioPharmaceuticals, Inc. and the buyers listed on the Schedule of Buyers thereto, dated January 12, 2018 (Filed With SEC on January 19, 2018)
- Preferred Stock Purchase Agreement by and among Alder BioPharmaceuticals, Inc. and the Buyers set forth therein dated January 7, 2018 (Filed With SEC on January 11, 2018)
- Underwriting Agreement, dated July 12, 2017 (Filed With SEC on July 14, 2017)
- ALDER BIOPHARMACEUTICALS, INC. 5,376,344 Shares of Common Stock Underwriting Agreement (Filed With SEC on April 8, 2016)
- 4,494,382 Shares ALDERBIOPHARMACEUTICALS, INC. COMMON STOCK UNDERWRITING AGREEMENT (Filed With SEC on June 26, 2015)
- [ ] Shares ALDER BIOPHARMACEUTICALS, INC. COMMON STOCK UNDERWRITING AGREEMENT (Filed With SEC on December 22, 2014)
- ALDER BIOPHARMACEUTICALS, INC. 2014 EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS:MARCH 31, 2014 APPROVED BY THE STOCKHOLDERS:APRIL 7, 2014 (Filed With SEC on May 1, 2014)
- ALDER BIOPHARMACEUTICALS, INC. AMENDMENT NO. 1 TO AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Filed With SEC on April 25, 2014)
- [ ] ALDER BIOPHARMACEUTICALS, INC. COMMON STOCK UNDERWRITING AGREEMENT (Filed With SEC on April 25, 2014)
- ALDER BIOPHARMACEUTICALS, INC. 2005 STOCK PLAN NOTICE OF STOCK OPTION GRANT (Filed With SEC on March 19, 2014)
- ALDER BIOPHARMACEUTICALS, INC. AMENDED AND RESTATED 2005 STOCK PLAN (Filed With SEC on March 19, 2014)
- ALDER BIOPHARMACEUTICALS, INC. AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT April 16, 2012 TABLE OF CONTENTS (Filed With SEC on March 19, 2014)
